|
|
Comments on Study Required by Section 989G(b) of the Dodd-Frank Act Regarding Compliance with Section 404(b) of the Sarbanes-Oxley Act
[Release No. 34-63108; File No. s7-29-10]
|
|
Dec. 10, 2013 | Edgar M. Dawai, Investor, Mombasa, Kenya |
Jan. 19, 2011 | Michael L. Gullette, Vice President, Accounting and Financial Management, American Bankers Association |
Dec. 16, 2010 | Grant Thornton LLP |
Dec. 15, 2010 | Georg Merkl, Binz, Switzerland |
Dec. 8, 2010 | Kurt N. Schacht, Managing Director, Standards and Financial Market Integrity Division, and James C. Allen, Head, Capital Markets Policy, CFA Institute |
Dec. 6, 2010 | Ernst & Young LLP |
Dec. 6, 2010 | Alan F. Eisenberg, Executive Vice President, Emerging Companies and Business Development, Biotechnology Industry Organization (BIO) |
Dec. 6, 2010 | Christopher Cole, Senior Vice President and Senior Regulatory Counsel, Independent Community Bankers of America |
Dec. 6, 2010 | Deloitte & Touche LLP |
Dec. 6, 2010 | Cynthia M.Fornelli, Executive Director, Center for Audit Quality |
Dec. 5, 2010 | James B. Vorhies, Arlington, Texas |
Dec. 1, 2010 | Jeff Mahoney, General Counsel, Council of Institutional Investors |
Nov. 5, 2010 | Stephen A. Boyko |
Oct. 27, 2010 | John L. Pierschbacher, Des Moines, Iowa |
Meetings with SEC Officials
|
Dec. 21, 2010 | Memorandum from the Office of Commissioner Walter regarding a November 17, 2010, meeting with representatives of BNY ConvergEx Group, LLC |
http://www.sec.gov/comments/s7-29-10/s72910.shtml
|